Drugmaker AbbVie plans to construct a $195 million facility near its headquarters in North Chicago to manufacture active pharmaceutical ingredients, The Chicago Tribune reported Aug. 12.
Construction is set to begin in the fall and is expected to be completed by 2027. The expansion adds to AbbVie’s large footprint in the state of Illinois, where it employs over 11,000 individuals across offices and manufacturing sites.
The new investment is also part of the state’s “Economic Development for a Growing Economy” program, which offers tax incentives to companies investing $100 million or more in Illinois.
The announcement follows similar moves by other large drugmakers, including AstraZeneca, Johnson & Johnson and Eli Lilly, to boost domestic manufacturing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
